Kahn Brothers Group recent buys & sells (2018 Q1)
Thomas Graham, Alan, Irving Kahns
Kahn Brothers Group Portfolio Changes
Purchase & sale details
- Portfolio value:
- $627.75M (-$9M)
- Previous value:
- $636.58M
- # of changes:
- 30
- New positions:
- 1
- Reported for:
- 31 Mar 2018 (Q1)
- Latest filing date:
- 01 May 2018
Kahn Brothers Group has disclosed a total of 30 changes to the portfolio in the (2018 Q1) SEC report(s): increased the number of shares of 7, bought 1 totally new, decreased the number of shares of 21 and completely sold out 1 position(s).
What stocks did Kahn Brothers Group buy in 2018 Q1?
During 2018 Q1 Kahn Brothers Group has bought 8 securities out of which top 5 purchases (by % change to portfolio) were (GSK) GlaxoSmithKline PLC ADR (added shares +8.03%), (AGO) ASSURED GUARANTY LTD (added shares +16.71%), (MBI) MBIA Inc (added shares +0.78%), (FLG) Flagstar Financial, Inc (added shares +15.96%) and (RFL) Rafael Holdings, Inc (new buy).
In the 2018 Q1 report(s) the following changes have been made to the top investments: (C) Citigroup Inc (reduced shares -3.40%), (BP) BP PLC-SPONS ADR (reduced shares -0.10%), (NYT) New York Times Company (reduced shares -22.36%), (BB) BlackBerry Ltd (reduced shares -1.88%) and (MRK) Merck & Company Inc (reduced shares -1.61%).
30 results
| History | Ticker | Name |
% or activity |
Shares change |
Shares held after* |
% change to portfolio |
Reported price* |
% difference current price* |
% of portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Rafael Holdings, Inc
|
new
|
$4.85
|
-71.13%($1.40)
|
0.25%
|
2018 Q1
|
~0.25 years
|
||||
|
|
Chevron Corp
|
+24.70%
|
$114.04
|
+96.83%($224.46)
|
0.09%
|
2013 Q2*
|
> 5 years
|
||||
|
|
ASSURED GUARANTY LTD
|
+16.71%
|
$36.20
|
+95.14%($70.64)
|
7.15%
|
2017 Q1
|
~1.25 years
|
||||
|
|
Flagstar Financial, Inc
|
+15.96%
|
$13.03
|
-14.27%($11.17)
|
4.57%
|
2013 Q2*
|
> 5 years
|
||||
|
|
GlaxoSmithKline PLC ADR
|
+8.03%
|
$48.84
|
+1.58%($49.61)
|
7.66%
|
2014 Q3
|
~3.75 years
|
||||
|
|
AT&T Inc
|
+7.35%
|
$35.65
|
-33.76%($23.62)
|
0.06%
|
2013 Q2*
|
> 5 years
|
||||
|
|
Bristol-Myers Squibb Company
|
+3.67%
|
$63.25
|
-4.11%($60.65)
|
0.20%
|
2013 Q2*
|
> 5 years
|
||||
|
|
MBIA Inc
|
+0.78%
|
$9.26
|
-52.70%($4.38)
|
6.82%
|
2013 Q2*
|
> 5 years
|
||||
|
|
BP PLC-SPONS ADR
|
-0.10%
|
$40.54
|
+23.43%($50.04)
|
9.08%
|
2013 Q2*
|
> 5 years
|
||||
|
|
IDT Corp
|
-0.25%
|
$6.27
|
+1,198.72%($81.43)
|
0.64%
|
2013 Q2*
|
> 5 years
|
||||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted. 2013 Q2 is the earliest period we have data for, so "2013 Q2*" means "2013 Q2 or earlier".